Pain Management Devices Market Size, Share and Industry Analysis By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Regional Forecast, 2019 - 2032

The global pain management devices market size was valued at USD 3,922.9 Million in 2018 and is projected to reach USD 14,123.9 Million by 2032, exhibiting a CAGR of 9.6% during the forecast period (2018-2032).

Neurostimulation, electric stimulation, and infusion pumps are widely prescribed by the physicians to eradicate chronic pain. According to a study conducted by the Centers for Disease Control and Prevention in 2016, an estimated 20.4% of the U.S. population was suffering from chronic pain. Neuromodulation technology works on the modulation and alternation of nerve activity with the help of electrical stimulations.

Another pain management device, TENS (Transcutaneous Electric Nerve Stimulation) operates on the same technological concept, however, the major difference between TENS and spinal cord stimulation lies in the placement of devices. TENS are placed on the skin, while spinal cord stimulation devices are implanted in the patient body. Growing prevalence of chronic pain and neuropathic conditions are projected to boost the adoption of pain management devices by 2026. This is expected to augment the pain management devices market growth in the forthcoming years.

"Neuromodulation Devices Segment Are Anticipated to Drive the Growth of the Pain Management Devices Market"

In 2018, neuromodulation devices held a significant share in the global market. Enabled by this, the pain management devices market size is expected to spur between 2018 and 2026. Neuromodulation devices stimulate the nervous system with the help of electrical impulses. These devices include spinal cord stimulation, deep brain stimulation, dorsal ganglion stimulation, and others. Deep brain stimulation plays an extensive role in the treatment of Parkinson’s disease, essential tremor, and dystonia.

Neuromodulation devices held an estimated 73.6% share in the global  market in 2018. Moreover, spinal cord stimulation amongst neuromodulation devices is expected to emerge as the fastest growing product type by 2026, aiding the pain management devices market share. Spinal cord stimulators are implanted in the body after a trial period and act as pain sensation inhibitors by stimulating low voltage electrical impulses in the nervous system.

Market Segmentation

In terms of applications, the market is categorized into musculoskeletal, brain, cancer, neuropathy, and others. The hospitals & clinics in end user segment are expected to register comparatively higher share in the Market owing to the higher utilization pain management devices for the treatment of several diseases in hospitals. This, in turn, is likely to foster the pain management devices revenue in the forecast years.

Regional Analysis

"Increasing Adoption Due to Range of Benefits Offered by Pain Management Devices Enables Market to Hold Considerable Share in North America"

The North America generated revenue of USD 3,032.0 Million in 2018 and is expected to dominate the market throughout the forecast period. Rapidly growing adoption of pain management devices is prominently expected to drive the growth of the North America pain management devices market during the forecast period. Moreover, rising per capita income, growing demand for drug-free therapy, and the growing prevalence of chronic pain conditions are projected to offer considerable opportunity for the growth of the North America market. According to data published by the International Neuromodulation Society, the number of FDA approvals for neuromodulation devices grew by an estimated 35.0% since the past decade.

Developed countries in Europe such as Germany, UK, and France are expected to drive the growth of the Europe market during the forecast period. Increasing adoption of technologically advanced devices, coupled with the increasing popularity of the pain management devices due to superior treatment outcomes is prominently projected to play a role in the growth of the Europe market. The Asia Pacific holds significant potential for the growth of the market during the forecast period. Certain factors such as developing healthcare research infrastructure, growing awareness about electrical stimulation techniques for pain management, and product penetration by established market players are anticipated to boost the market in the Asia Pacific.

Key Market Drivers 

"Medtronic and Boston Scientific Corporation to Account for the Significant Market Share in Terms of Revenue"

Medtronic is a significant player in the market. Medtronic is estimated to maintain its leading position in the market owing to the wide product portfolio, robust distribution network, and implementation of strategic marketing policies. This company, together with Boston Scientific Corporation, currently holds maximum share in the global market. Other players operating in the pain management devices market are LivaNova, Abbott, and others.

List of key Companies Profiled:

• Medtronic


• Boston Scientific Corporation


• LivaNova


• Abbott


• DJO Global LLC


• SPR Therapeutics


• Nevro Corp


• Other Prominent Players

KEY INDUSTRY DEVELOPMENTS:

• May 2021 - NeuraLace Medical, Inc., a medical device company announced that company has enrolled the first patient as part of the AXON-RCT U.S. Axon Therapy is a therapy that provide relief from chronic nerve pain as it brings focused magnetic pulses which activate the damaged peripheral nerve axons which are required


• March 2021 - Hinge Health, a Digital Musculoskeletal Clinic, made an announcement of the acquisition of the maker of Enso, a clinically validated non-invasive technology which helps people with musculoskeletal (MSK) pain. This acquisition of Hinge Health’s Digital MSK Clinic with Enso’s technology opens a new world of pain management.


• January 2021 - Boston Scientific has announced the launch of WaveWriter Alpha, a Spinal Cord Stimulator (SCS) systems designed to address challenges in pain management. The SCS portfolio features portfolio of conditional devices that provides Fast Acting Sub-Perception Therapy (FAST) which is designed to deliver pain relief in minutes.


• January 2021 - Abbott made an announcement about the company’s upcoming launch of NeuroSphere myPath which is a digital health app designed to track and record the patient outcomes on pain and well-being related with spinal cord stimulation (SCS) therapy. It is a digital innovation that will help to provide relief to people living with chronic pain that are eligible for SCS or DRG therapy.

Report Coverage

Pain management devices block the pain sensation generated in the body with the help of electrical signals. Certain techniques such as neuromodulation, electrical stimulation, programmed infusion pumps, radiofrequency ablation, and others are prominently used to treat chronic pain. Rapidly increasing prevalence of chronic pain is anticipated to drive the pain management devices market growth during the forecast period. More researches are being conducted by market players and research institutes to validate the applications of electrical stimulation techniques in the efficacy of neurorehabilitation. 

The pain management devices market report provides qualitative and quantitative insights on industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The global market segments include product type, applications, end user, and region. On the basis of the product type, the market is segmented into electrical stimulation devices, neuromodulation devices, RF ablation devices, and infusion pumps. Electrical stimulation devices are further sub-segmented into TENS (Transcutaneous Electric Nerve Stimulation), EMS (Electric Muscle Stimulation), and others. Neuromodulation devices are sub-segmented as spinal cord stimulation, deep brain stimulation, and others. On the basis of applications, the market is segmented as musculoskeletal, brain, cancer, neuropathy, and others. End users covered under the report are physiotherapy centers, hospitals & clinics, and others (home care settings & ambulatory surgery centers). Geographically, the market is segmented into major regions, which are North America, Europe, Asia Pacific, and the rest of the world. The regions are further categorized into countries.

Along with this, the report provides elaborative analysis of the market dynamics and competitive landscape. Various key insights provided in the report are recent industry developments- partnerships, mergers, and acquisitions, technological advancements in the market, epidemics of chronic pain for key countries, new product launch by key players, and key industry trends.

SEGMENTATION